Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ClC-Kb pore mutation disrupts glycosylation and triggers distal tubular remodeling
Yogita Sharma, … , Oleh Pochynyuk, Vivek Bhalla
Yogita Sharma, … , Oleh Pochynyuk, Vivek Bhalla
Published October 15, 2024
Citation Information: JCI Insight. 2024;9(22):e175998. https://doi.org/10.1172/jci.insight.175998.
View: Text | PDF
Research Article Nephrology

ClC-Kb pore mutation disrupts glycosylation and triggers distal tubular remodeling

  • Text
  • PDF
Abstract

Mutations in the CLCNKB gene (1p36), encoding the basolateral chloride channel ClC-Kb, cause type 3 Bartter syndrome. We identified a family with a mixed Bartter/Gitelman phenotype and early-onset kidney failure and by employing a candidate gene approach, identified what we believe is a novel homozygous mutation (CLCNKB c.499G>T [p.Gly167Cys]) in exon 6 of CLCNKB in the index patient. We then validated these results with Sanger and whole-exome sequencing. Compared with wild-type ClC-Kb, the Gly167Cys mutant conducted less current and exhibited impaired complex N-linked glycosylation in vitro. We demonstrated that loss of Gly-167, rather than gain of a mutant Cys, impairs complex glycosylation, but that surface expression remains intact. Moreover, Asn-364 was necessary for channel function and complex glycosylation. Morphologic evaluation of human kidney biopsies revealed typical basolateral localization of mutant Gly167Cys ClC-Kb in cortical distal tubular epithelia. However, we detected attenuated expression of distal sodium transport proteins, changes in abundance of distal tubule segments, and hypokalemia-associated intracellular condensates from the index patient compared with control nephrectomy specimens. The present data establish what we believe are novel regulatory mechanisms of ClC-Kb activity and demonstrate nephron remodeling in humans, caused by mutant ClC-Kb, with implications for renal electrolyte handling, blood pressure control, and kidney disease.

Authors

Yogita Sharma, Robin Lo, Viktor N. Tomilin, Kotdaji Ha, Holly Deremo, Aishwarya V. Pareek, Wuxing Dong, Xiaohui Liao, Svetlana Lebedeva, Vivek Charu, Neeraja Kambham, Kerim Mutig, Oleh Pochynyuk, Vivek Bhalla

×

Figure 1

The Gly167Cys ClC-Kb mutation is inherited in an autosomal recessive pattern and disrupts a conserved glycine along the main pore of the channel.

Options: View larger image (or click on image) Download as PowerPoint
The Gly167Cys ClC-Kb mutation is inherited in an autosomal recessive pat...
(A) Pedigree showing the index patient (blue arrow) and his brother affected by the phenotype (shaded blue). (B) Gene sequencing of CLCNKB exon 6 shows a homozygous G499T point mutation. (C) Multiple sequence alignment of human ClC family proteins and ClC-Kb across the species shows the conservation of glycine at position 167 (G). (D) RT-PCR of cDNA from peripheral blood mononuclear cells demonstrating lack of splicing from exon 4 to 6 (n = 1). M, marker.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts